Trial information
A Study of Risk Stratification in Patients With Suspected Lung Cancer.
Status: Recruiting
Protocol number: RD000000392-2006
Company division: Diagnostic
Official Scientific Title: Evaluation of tumor markers for the risk stratification of patients with suspicion of lung cancer.
Brief summary: This study will evaluate tumor marker utility as a diagnostic tool for the stratification of patients with a risk of developing lung cancer. Patients presenting with clinical signs suggestive of lung cancer will be tested at 3, 6 and 12 months, to establish tumor marker sensitivity, and the best combination of markers for the diagnosis of lung cancer.
Condition: Lung Cancer
Intervention type: Diagnostic Test
Intervention name: ELECSYS test kits (CEA II, Cyfra, CA 125, NSE, CA15-3 II, CA19-911 (100X5), CA72-4 RP)
Inclusion criteria:
- adult patients, >=18 years of age;
- presenting with signs suggestive of lung cancer (thoracic pain, hemoptysis, tumor mass).
Exclusion criteria:
- previously diagnosed lung cancer or other malignancies;
- jaundice.
Gender: Males or Females
Age limits: Min: 18 Years Max: 99 Years
Accepts healthy volunteers: No
Anticipated start date: November, 2006
Trial registration date: 12/06/2006
Date last updated: 11/21/2008
Link to trial result
This trial is being conducted at the following locations:
Spain
- Barcelona
- Manresa
- San Sebastian
- Santiago
- Sevilla
